Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001790340-25-000098
Filing Date
2025-07-07
Accepted
2025-07-07 08:59:25
Documents
1
Period of Report
2025-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751893158.html 4  
1 FORM 4 wk-form4_1751893158.xml 4 4574
  Complete submission text file 0001790340-25-000098.txt   6094
Mailing Address C/O ONCOTHYREON INC. 2601 FOURTH AVE, SUITE 500 SEATTLE WA 98121
Business Address
HAUSMAN DIANA (Reporting) CIK: 0001563992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40675 | Film No.: 251107080

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)